ROYCE & ASSOCIATES LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 104 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$37,000
-92.4%
14,118
-93.4%
0.00%
-100.0%
Q4 2014$489,000
+17.0%
215,3920.0%0.00%
+100.0%
Q3 2014$418,000
-46.5%
215,3920.0%0.00%
-50.0%
Q2 2014$782,000
-34.8%
215,392
-30.4%
0.00%
-50.0%
Q1 2014$1,200,000
+36.2%
309,392
+0.1%
0.00%
+33.3%
Q4 2013$881,0000.0%308,992
+25.6%
0.00%0.0%
Q3 2013$881,000
+7.2%
246,0000.0%0.00%0.0%
Q2 2013$822,000246,0000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders